Titan Pharmaceuticals, Inc.
TTNP
$4.24
-$0.21-4.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -68.42% | -58.12% | -58.02% | 3,797.14% | 442.17% |
| Total Receivables | -39.55% | -94.07% | -96.59% | 322.22% | 1,575.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -59.12% | -84.92% | -38.11% | -3.93% | -21.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -67.39% | -63.54% | -63.61% | 773.49% | 270.36% |
|
|
|||||
| Total Current Assets | -67.39% | -63.54% | -63.61% | 773.49% | 270.36% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -89.55% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -67.56% | -63.85% | -63.98% | 435.71% | 206.55% |
|
|
|||||
| Total Accounts Payable | -47.71% | -41.95% | -8.85% | -40.37% | -34.57% |
| Total Accrued Expenses | -45.16% | -45.86% | -- | -- | -89.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -73.60% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -50.09% | -66.55% | -80.12% | -80.72% | -77.16% |
|
|
|||||
| Total Current Liabilities | -50.09% | -66.55% | -80.12% | -80.72% | -77.16% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -50.09% | -66.55% | -80.12% | -80.72% | -77.46% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.13% | 0.25% | 2.70% | 2.93% |
| Retained Earnings | -1.07% | -1.20% | -1.51% | -1.40% | -1.28% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -69.18% | -63.27% | -60.28% | 486.17% | 2,050.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -- | -- |
|
|
|||||
| Total Common Equity | -69.18% | -63.27% | -60.28% | 486.17% | 2,050.64% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -69.16% | -63.26% | -60.27% | 486.27% | 2,050.96% |
|
|
|||||